128 related articles for article (PubMed ID: 38608989)
1. Natural product guvermectin inhibits guanosine 5'-monophosphate synthetase and confers broad-spectrum antibacterial activity.
Zhang M; Li L; Li C; Ma A; Li J; Yang C; Chen X; Cao P; Li S; Zhang Y; Yuchi Z; Du X; Liu C; Wang X; Wang X; Xiang W
Int J Biol Macromol; 2024 May; 267(Pt 2):131510. PubMed ID: 38608989
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity and oligomerization of human GMP synthetase.
Welin M; Lehtiö L; Johansson A; Flodin S; Nyman T; Trésaugues L; Hammarström M; Gräslund S; Nordlund P
J Mol Biol; 2013 Nov; 425(22):4323-33. PubMed ID: 23816837
[TBL] [Abstract][Full Text] [Related]
3. N2-hydroxyguanosine 5'-monophosphate is a time-dependent inhibitor of Escherichia coli guanosine monophosphate synthetase.
Deras ML; Chittur SV; Davisson VJ
Biochemistry; 1999 Jan; 38(1):303-10. PubMed ID: 9890911
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of biotin carboxylase inhibition by ethyl 4-[[2-chloro-5-(phenylcarbamoyl)phenyl]sulphonylamino]benzoate.
Craft MK; Waldrop GL
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):100-108. PubMed ID: 34894987
[TBL] [Abstract][Full Text] [Related]
5. GMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway.
Li Q; Leija C; Rijo-Ferreira F; Chen J; Cestari I; Stuart K; Tu BP; Phillips MA
Mol Microbiol; 2015 Sep; 97(5):1006-20. PubMed ID: 26043892
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.
Wang Q; Guan YF; Hancock SE; Wahi K; van Geldermalsen M; Zhang BK; Pang A; Nagarajah R; Mak B; Freidman N; Horvath LG; Turner N; Holst J
J Pathol; 2021 Jun; 254(2):135-146. PubMed ID: 33768538
[TBL] [Abstract][Full Text] [Related]
7. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
8. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
[TBL] [Abstract][Full Text] [Related]
9. Computational redesign of bacterial biotin carboxylase inhibitors using structure-based virtual screening of combinatorial libraries.
Brylinski M; Waldrop GL
Molecules; 2014 Apr; 19(4):4021-45. PubMed ID: 24699146
[TBL] [Abstract][Full Text] [Related]
10. Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection.
Zang P; Gong A; Zhang P; Yu J
Pharm Biol; 2016; 54(4):604-18. PubMed ID: 26681298
[TBL] [Abstract][Full Text] [Related]
11. Increased fermentative adenosine production by gene-targeted Bacillus subtilis mutation.
Li B; Yan ZY; Liu XN; Zhou J; Wu XY; Wei P; Jia HH; Yong XY
J Biotechnol; 2019 Jun; 298():1-4. PubMed ID: 30974118
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
[TBL] [Abstract][Full Text] [Related]
13. Smaller is better for antibiotic discovery.
Waldrop GL
ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
[TBL] [Abstract][Full Text] [Related]
14. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches.
Mochalkin I; Miller JR; Narasimhan L; Thanabal V; Erdman P; Cox PB; Prasad JV; Lightle S; Huband MD; Stover CK
ACS Chem Biol; 2009 Jun; 4(6):473-83. PubMed ID: 19413326
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the inhibition of human 5,10-methenyltetrahydrofolate synthetase by N10-substituted folate analogues.
Wu D; Li Y; Song G; Cheng C; Zhang R; Joachimiak A; Shaw N; Liu ZJ
Cancer Res; 2009 Sep; 69(18):7294-301. PubMed ID: 19738041
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinase inhibitors as potential antibacterial agents.
Yuan Y; Jin W; Nazir Y; Fercher C; Blaskovich MAT; Cooper MA; Barnard RT; Ziora ZM
Eur J Med Chem; 2020 Feb; 187():111892. PubMed ID: 31810785
[TBL] [Abstract][Full Text] [Related]
17. Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & Niazirin.
Dwivedi GR; Maurya A; Yadav DK; Khan F; Gupta MK; Gupta P; Darokar MP; Srivastava SK
Curr Top Med Chem; 2019; 19(10):847-860. PubMed ID: 30977451
[TBL] [Abstract][Full Text] [Related]
18. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
[TBL] [Abstract][Full Text] [Related]
19. The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine.
Nakamura J; Straub K; Wu J; Lou L
J Biol Chem; 1995 Oct; 270(40):23450-5. PubMed ID: 7559506
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Antimicrobial Evaluation and Molecular Docking of Some Potential 2,6-disubstituted 1H-Benzimidazoles; Non-Classical Antifolates.
Harer S; Bhatia M; Kawade V
Med Chem; 2019; 15(7):813-832. PubMed ID: 30727904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
